Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.

Source:http://linkedlifedata.com/resource/pubmed/id/10671405

Download in:

View as

General Info

PMID
10671405